NCT01871974View on ClinicalTrials.gov

Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Major Depressive Disorder Patients
Interventions
DRUG

FK949E

oral

Trial Locations (2)

Unknown

Kansai

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY